Use of Mono Mac 6 human monocytic cell line and J774 murine macrophage cell line in parallel antimycobacterial drug studies.
The Mono Mac 6 (MM6) human monocytic cell line was evaluated with the established J774 murine macrophage cell line to ascertain its effectiveness in determining the intracellular activities of antimycobacterial drugs. Cells were infected with Mycobacterium tuberculosis H37Ra and treated with drug concentrations corresponding to the MICs, as well as to threefold higher than and threefold less than the MICs. Changes in CFU were compared after 7 days to determine significant differences between treated and nontreated groups. The results suggest that MM6 will make a useful model for testing the intracellular activities of antituberculosis drugs.
Wright
E L
EL
Mycobacteriology Research Unit, Southern Research Institute, Birmingham, Alabama 35205, USA.
Quenelle
D C
DC
Suling
W J
WJ
Barrow
W W
WW
D000818:Animals; D000995:Antitubercular Agents / Q000494:pharmacology*; D002460:Cell Line; D002470:Cell Survival; D015169:Colony Count, Microbial; D006801:Humans; D008264:Macrophages / Q000187:drug effects / Q000382:microbiology*; D051379:Mice; D008826:Microbial Sensitivity Tests; D009000:Monocytes / Q000187:drug effects / Q000382:microbiology*; D009169:Mycobacterium tuberculosis / Q000187:drug effects*
D000995:Antitubercular Agents